摘要
取代苯胺经酰化、环合反应制得关键中间体取代靛红衍生物4a~4k,再用三乙基硅烷/三氟乙酸体系室温还原制得取代-1,3-二氢吲哚-2-酮类化合物1a~1k,后者可用于合成舒尼替尼等酪氨酸激酶抑制剂类抗肿瘤药。
The substituted 1,3-dihydroindo-2-one compounds 1a - 1k, the intermediates of tyrosine kinase inhibitors such as sunitinib, were synthesized from substituted anilines by acylation and cyclization to give substituted isatin derivatives 4a - 4k, followed by reduction with triethylsilane/trifluoroacetic acid.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2013年第7期660-662,668,共4页
Chinese Journal of Pharmaceuticals
基金
国家自然科学基金(21172260)
上海市基础研究重点课题(09JC1417500)